Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $9.33M in the quarter ending June 30, 2026, a decrease of -32.51%. This brings the company's revenue in the last twelve months to $27.59M, down -86.20% year-over-year. In the year 2025, Stoke Therapeutics had annual revenue of $184.42M with 404.50% growth.

• Revenue (ttm): $27.59M
• Revenue Growth: -86.20%
• P/S Ratio: 59.64
• Revenue / Employee: $162,282
• Employees: 170
• Market Cap: 1.65B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	184.42M	147.87M	404.50%
Dec 31, 2024	36.56M	27.78M	316.34%
Dec 31, 2023	8.78M	-3.63M	-29.22%
Dec 31, 2022	12.41M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 26, 2026

Data Sources Report a data error